These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 34990700)

  • 21. Smart albumin-loaded Rose Bengal and doxorubicin nanoparticles for breast cancer therapy.
    Sun J; Zhang L; Zhang Y; Yue CW; Lin J; Wang H; Fang ZJ; Wu J
    J Microencapsul; 2019 Dec; 36(8):728-737. PubMed ID: 31544561
    [No Abstract]   [Full Text] [Related]  

  • 22. Engineering of Bone- and CD44-Dual-Targeting Redox-Sensitive Liposomes for the Treatment of Orthotopic Osteosarcoma.
    Feng S; Wu ZX; Zhao Z; Liu J; Sun K; Guo C; Wang H; Wu Z
    ACS Appl Mater Interfaces; 2019 Feb; 11(7):7357-7368. PubMed ID: 30682240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone mineral: A trojan horse for bone cancers. Efficient mitochondria targeted delivery and tumor eradication with nano hydroxyapatite containing doxorubicin.
    Liu Y; Nadeem A; Sebastian S; Olsson MA; Wai SN; Styring E; Engellau J; Isaksson H; Tägil M; Lidgren L; Raina DB
    Mater Today Bio; 2022 Mar; 14():100227. PubMed ID: 35265825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An overview on the delivery of antitumor drug doxorubicin by carrier proteins.
    Agudelo D; Bérubé G; Tajmir-Riahi HA
    Int J Biol Macromol; 2016 Jul; 88():354-60. PubMed ID: 27037051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Porous nano-hydroxyapatite/collagen scaffold containing drug-loaded ADM-PLGA microspheres for bone cancer treatment.
    Rong ZJ; Yang LJ; Cai BT; Zhu LX; Cao YL; Wu GF; Zhang ZJ
    J Mater Sci Mater Med; 2016 May; 27(5):89. PubMed ID: 26975746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HSA-based multi-target combination therapy: regulating drugs' release from HSA and overcoming single drug resistance in a breast cancer model.
    Gou Y; Zhang Z; Li D; Zhao L; Cai M; Sun Z; Li Y; Zhang Y; Khan H; Sun H; Wang T; Liang H; Yang F
    Drug Deliv; 2018 Nov; 25(1):321-329. PubMed ID: 29350051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of a novel biocompatible magnetic nanomedicine based on beta-cyclodextrin, loaded doxorubicin-curcumin for overcoming chemoresistance in breast cancer.
    Rastegar R; Akbari Javar H; Khoobi M; Dehghan Kelishadi P; Hossein Yousefi G; Doosti M; Hossien Ghahremani M; Shariftabrizi A; Imanparast F; Gholibeglu E; Gholami M
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):207-216. PubMed ID: 29688063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-CD19 mAb-conjugated human serum albumin nanoparticles effectively deliver doxorubicin to B-lymphoblastic leukemia cells.
    Pan H; Li S; Li M; Tao Q; Jia J; Li W; Wang L; Guo Z; Ma K; Liu Y; Cui C
    Pharmazie; 2020 Jul; 75(7):318-323. PubMed ID: 32635973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human serum albumin-based doxorubicin prodrug nanoparticles with tumor pH-responsive aggregation-enhanced retention and reduced cardiotoxicity.
    Zhang B; Wan S; Peng X; Zhao M; Li S; Pu Y; He B
    J Mater Chem B; 2020 May; 8(17):3939-3948. PubMed ID: 32236239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Doxorubicin-Loaded Human Serum Albumin Submicron Particles: Preparation, Characterization and In Vitro Cellular Uptake.
    Chaiwaree S; Prapan A; Suwannasom N; Laporte T; Neumann T; Pruß A; Georgieva R; Bäumler H
    Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32131545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Doxorubicin-loaded human serum albumin nanoparticles surface-modified with TNF-related apoptosis-inducing ligand and transferrin for targeting multiple tumor types.
    Bae S; Ma K; Kim TH; Lee ES; Oh KT; Park ES; Lee KC; Youn YS
    Biomaterials; 2012 Feb; 33(5):1536-46. PubMed ID: 22118776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Folate-modified gold nanoclusters as near-infrared fluorescent probes for tumor imaging and therapy.
    Chen H; Li S; Li B; Ren X; Li S; Mahounga DM; Cui S; Gu Y; Achilefu S
    Nanoscale; 2012 Sep; 4(19):6050-64. PubMed ID: 22930451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single Protein Encapsulated Doxorubicin as an Efficacious Anticancer Therapeutic.
    Yu C; Huang F; Chow WA; Cook-Wiens G; Cui X
    Adv Ther (Weinh); 2020 Nov; 3(11):. PubMed ID: 33709014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probing the binding sites of antibiotic drugs doxorubicin and N-(trifluoroacetyl) doxorubicin with human and bovine serum albumins.
    Agudelo D; Bourassa P; Bruneau J; Bérubé G; Asselin E; Tajmir-Riahi HA
    PLoS One; 2012; 7(8):e43814. PubMed ID: 22937101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secreted protein acidic and rich in cysteine mediates active targeting of human serum albumin in U87MG xenograft mouse models.
    Park CR; Jo JH; Song MG; Park JY; Kim YH; Youn H; Paek SH; Chung JK; Jeong JM; Lee YS; Kang KW
    Theranostics; 2019; 9(24):7447-7457. PubMed ID: 31695779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetically Encoding Albumin Binding into Chemotherapeutic-loaded Polypeptide Nanoparticles Enhances Their Antitumor Efficacy.
    Yousefpour P; McDaniel JR; Prasad V; Ahn L; Li X; Subrahmanyan R; Weitzhandler I; Suter S; Chilkoti A
    Nano Lett; 2018 Dec; 18(12):7784-7793. PubMed ID: 30461287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Importance of the fatty acid chain length on in vitro and in vivo anticancer activity of fattigation-platform albumin nanoparticles in human colorectal cancer xenograft mice model.
    Park C; Baek N; Loebenberg R; Lee BJ
    J Control Release; 2020 Aug; 324():55-68. PubMed ID: 32380202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chitooligosaccharides Modified Reduction-Sensitive Liposomes: Enhanced Cytoplasmic Drug Delivery and Osteosarcomas-Tumor Inhibition in Animal Models.
    Yin X; Chi Y; Guo C; Feng S; Liu J; Sun K; Wu Z
    Pharm Res; 2017 Oct; 34(10):2172-2184. PubMed ID: 28726003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Doxorubicin-loaded glycyrrhetinic acid modified recombinant human serum albumin nanoparticles for targeting liver tumor chemotherapy.
    Qi WW; Yu HY; Guo H; Lou J; Wang ZM; Liu P; Sapin-Minet A; Maincent P; Hong XC; Hu XM; Xiao YL
    Mol Pharm; 2015 Mar; 12(3):675-83. PubMed ID: 25584860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low molecular weight heparin modified bone targeting liposomes for orthotopic osteosarcoma and breast cancer bone metastatic tumors.
    Wu H; Luo Y; Xu D; Ke X; Ci T
    Int J Biol Macromol; 2020 Dec; 164():2583-2597. PubMed ID: 32795579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.